How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

11,625 results for

Intrauterine Device

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

21. Progestin therapy for obese women with complex atypical hyperplasia: levonorgestrel-releasing intrauterine device vs systemic therapy. (Abstract)

Progestin therapy for obese women with complex atypical hyperplasia: levonorgestrel-releasing intrauterine device vs systemic therapy. Though hysterectomy remains the standard treatment for complex atypical hyperplasia, patients who desire fertility or who are poor surgical candidates may opt for progestin therapy. However, the effectiveness of the levonorgestrel-releasing intrauterine device compared to systemic therapy in the treatment of complex atypical hyperplasia has not been well (...) studied.We sought to examine differences in treatment response between local progestin therapy with the levonorgestrel-releasing intrauterine device and systemic progestin therapy in women with complex atypical hyperplasia.This single-institution retrospective study examined women with complex atypical hyperplasia who received progestin therapy between 2003 and 2018. Treatment response was assessed by histopathology on subsequent biopsies. Time-dependent analyses of complete response and progression

2020 American Journal of Obstetrics and Gynecology

22. Ultrasound location of intrauterine devices placed at cesarean section over the first year postpartum. Full Text available with Trip Pro

Ultrasound location of intrauterine devices placed at cesarean section over the first year postpartum. The primary objective was to measure IUD-fundus and IUD-myometrium distances by ultrasound of IUDs placed during cesarean section over the first year of use. The secondary objective was to determine if these distances are associated with risk of expulsion or removal for side effects.In this prospective observational study, we performed ultrasounds at six - ten weeks, three months and one year (...) who did or did not experience expulsion or removal by one year.Position of intrauterine devices placed during cesarean section was similar for those who did or did not have expulsion or removal for symptoms in the first year after placement. These data may help in the design of future studies to determine if ultrasound measurement of IUDs predicts IUD complications.Copyright © 2020 Elsevier Inc. All rights reserved.

2020 Contraception

23. The effect of antenatal counseling and intrauterine device insertion services on postpartum contraceptive use in Nepal: Results from a stepped-wedge randomized controlled trial. Full Text available with Trip Pro

The effect of antenatal counseling and intrauterine device insertion services on postpartum contraceptive use in Nepal: Results from a stepped-wedge randomized controlled trial. There is high unmet need for family planning in the postpartum period in Nepal. The current study assessed the effects of a contraceptive counseling and postpartum intrauterine device (PPIUD) insertion intervention on use of contraception in the postpartum period.We utilized a cluster, stepped-wedge design to randomly

2020 Contraception

24. Prophylactic vaginal dinoprostone administration six hours prior to copper-T380A intrauterine device insertion in nulliparous women: A randomized controlled trial. Full Text available with Trip Pro

Prophylactic vaginal dinoprostone administration six hours prior to copper-T380A intrauterine device insertion in nulliparous women: A randomized controlled trial. To determine the effectiveness of 3 mg vaginal dinoprostone administered six hours prior to copper intrauterine device (IUD) insertion compared to placebo in increasing ease of insertion and reducing insertion pain among nulliparous women.This was a single-center double-blinded randomized controlled trial (RCT). We randomly divided

2020 Contraception

25. Postplacental placement of intrauterine devices: A randomized clinical trial. Full Text available with Trip Pro

Postplacental placement of intrauterine devices: A randomized clinical trial. To compare the expulsion rate of the TCu380A intrauterine device (IUD) or levonorgestrel (LNG) 52 mg intrauterine system (IUS) up to 90 days after postplacental placement (10 min after delivery of the placenta).Randomized trial (1:1) of women aged 18-43 years and ≥37 weeks pregnant enrolled during early or prodromal labor at the University of Campinas, Brazil. Follow-up was scheduled at 42 and 90 days after device (...) those who had a Cesarean delivery. Most of the expulsions occurred within 42 days.Policy makers should increase the availability of both the TCu380A and the LNG intrauterine devices for the immediate postpartum period, even though the expulsion rate is higher than that after interval placement.Copyright © 2019 Elsevier Inc. All rights reserved.

2020 Contraception

26. Long-Term Incidence of Infectious-Related Hospitalizations of Offspring Born to Mothers With Intrauterine Device: A Retrospective Population-Based Cohort Study. (Abstract)

Long-Term Incidence of Infectious-Related Hospitalizations of Offspring Born to Mothers With Intrauterine Device: A Retrospective Population-Based Cohort Study. Pregnancy with an Intrauterine device (IUD) is a risk factor for adverse pregnancy outcomes. The purpose of this study was to examine a possible association between presence of IUD during pregnancy and long-term incidence of infectious-related hospitalizations of the offspring.A population-based cohort analysis was performed including (...) were to mothers who conceived with an IUD that was removed and 52 were to mothers who retained their device. Long-term incidence of infections-related hospitalizations was compared between the groups (12.5% in the retained IUD, 12.9% in the removed IUD and 11.2% in the No-IUD group, P = 0.638). A Kaplan-Meier survival curve did not demonstrate a significantly higher cumulative incidence of infectious-related hospitalizations in offspring of women who conceived with an IUD (log-rank P = 0.340

2020 Pediatric Infectious Dsease Journal

27. Bleeding pattern difference between levonorgestrel-intrauterine system and copper-intrauterine devices inserted immediately post-abortion: a multicenter, prospective, observational cohort study in Chinese women. (Abstract)

Bleeding pattern difference between levonorgestrel-intrauterine system and copper-intrauterine devices inserted immediately post-abortion: a multicenter, prospective, observational cohort study in Chinese women. To describe the bleeding pattern (primary outcome), side effects, treatment satisfaction and 6 month continuity rates associated with the 52 mg levonorgestrel intrauterine system (LNG-IUS) and the copper intrauterine device (Cu-IUD) inserted immediately after abortion.This multicenter

2018 Current medical research and opinion

28. Safety of intrauterine devices in MRI. Full Text available with Trip Pro

Safety of intrauterine devices in MRI. The paucity of safety information on intrauterine devices (IUD) for magnetic resonance imaging (MRI) examinations is clinically relevant. The aim of this study is to evaluate the MRI safety of clinically used IUDs composed of copper/gold and stainless steel at 1.5T and 3.0T.We assessed and compared the displacement force, torque effects, presence of imaging artifacts and heating of IUDs composed of copper/gold (western IUDs) and stainless steel (China

2018 PLoS ONE

29. Cervico-vaginal inflammatory cytokine alterations after intrauterine contraceptive device insertion: A pilot study. Full Text available with Trip Pro

Cervico-vaginal inflammatory cytokine alterations after intrauterine contraceptive device insertion: A pilot study. In a prospective study of twenty sexually transmitted infection (STI)-free women, we examined the impact of an intrauterine contraceptive device (IUCD) insertion on cervico-vaginal cytokine levels. Nine women chose the levonorgestrel-containing IUCD and eight chose a copper IUCD. A cervico-vaginal swab was collected for cytokine analysis pre-insertion and four weeks post-insertion

2018 PLoS ONE

30. Endoscopic Treatment of Intrauterine Device Migration into the Bladder with Stone Formation Full Text available with Trip Pro

Endoscopic Treatment of Intrauterine Device Migration into the Bladder with Stone Formation Background: An intrauterine device is commonly used for contraception globally. Although intrauterine device placement is an effective and safe method of contraception, migration into the bladder with stone formation is a rare and serious complication. The management approaches for an intrauterine device embedded in the bladder include endoscopic procedures and open surgical removal. In this study, we (...) report the case of a patient with recurrent urinary tract infection associated with intrauterine device migration and urolithiasis, who successfully underwent endoscopic treatment combined with laser fragmentation. Case Presentation: A 22-year-old woman presented to our hospital with a 1-month history of lower abdominal pain, hematuria, and pain on urination. Transvaginal ultrasound showed a hyperechoic lesion in the bladder. A plain abdominal radiograph showed the presence of a T-shaped intrauterine

2017 Journal of endourology case reports

31. Best Practices to Minimize Risk of Infection With Intrauterine Device Insertion

Best Practices to Minimize Risk of Infection With Intrauterine Device Insertion Best Practices to Minimize Risk of Infection With Intrauterine Device Insertion - Journal of Obstetrics and Gynaecology Canada Email/Username: Password: Remember me Search Terms Search within Search Volume 36, Issue 3, Pages 266–274 Best Practices to Minimize Risk of Infection With Intrauterine Device Insertion PRINCIPAL AUTHORS, x Sheila Caddy , MD Edmonton AB x Mark H. Yudin , MD Toronto ON x Julie Hakim , MD (...) SPECIAL CONTRIBUTOR x Wendy V. Norman , MD x Wendy V. Norman DOI: To view the full text, please login as a subscribed user or . Click to view the full text on ScienceDirect. Abstract Background Intrauterine devices provide an extremely effective, long-term form of contraception that has the benefit of being reversible. Historically, the use of certain intrauterine devices was associated with increased risk of pelvic inflammatory disease. More recent evidence suggests that newer devices do not carry

2014 Society of Obstetricians and Gynaecologists of Canada

32. Increasing Access to Contraceptive Implants and Intrauterine Devices to Reduce Unintended Pregnancy

Increasing Access to Contraceptive Implants and Intrauterine Devices to Reduce Unintended Pregnancy Increasing Access to Contraceptive Implants and Intrauterine Devices to Reduce Unintended Pregnancy - ACOG Menu ▼ Increasing Access to Contraceptive Implants and Intrauterine Devices to Reduce Unintended Pregnancy Page Navigation ▼ Number 642, October 2015 (Replaces Committee Opinion Number 450, December 2009) (Reaffirmed 2018) Committee on Gynecologic Practice Long-Acting Reversible (...) Contraception Working Group This document reflects emerging clinical and scientific advances as of the date issued and is subject to change. The information should not be construed as dictating an exclusive course of treatment or procedure to be followed. Increasing Access to Contraceptive Implants and Intrauterine Devices to Reduce Unintended Pregnancy ABSTRACT: Unintended pregnancy persists as a major public health problem in the United States. Although lowering unintended pregnancy rates requires

2015 American College of Obstetricians and Gynecologists

33. Emergency contraception: an intrauterine device is preferable in cases of overweight and obesity

Emergency contraception: an intrauterine device is preferable in cases of overweight and obesity Prescrire IN ENGLISH - Spotlight ''Emergency contraception: an intrauterine device is preferable in cases of overweight and obesity'', 1 December 2014 {1} {1} {1} | | > > > Emergency contraception: an intrauterine device is preferable in cases of overweight and obesity Spotlight Every month, the subjects in Prescrire’s Spotlight. 100 most recent :  |   |   |   |  (...)  |   |   |   |   |  Spotlight Emergency contraception: an intrauterine device is preferable in cases of overweight and obesity For overweight or obese women requiring emergency contraception, the fitting of an intrauterine device (IUD) is the first choice. Fitting a copper IUD within 5 days of unprotected sexual intercourse is a very effective means of postcoital or emergency contraception. A single dose of the progestin contraceptive levonorgestrel

2014 Prescrire

34. Best Practices to Minimize Risk of Infection With Intrauterine Device Insertion

Best Practices to Minimize Risk of Infection With Intrauterine Device Insertion 404 Toggle navigation Toggle search Keyword search language Keyword search 404 Error Page/Asset Not Found The Society of Obstetricians and Gynaecologists of Canada (SOGC) {1} {1} {1}

2014 Society of Obstetricians and Gynaecologists of Canada

35. Factors affecting the behavior outcomes on post-partum intrauterine contraceptive device uptake and continuation in Nepal: a qualitative study. Full Text available with Trip Pro

Factors affecting the behavior outcomes on post-partum intrauterine contraceptive device uptake and continuation in Nepal: a qualitative study. The use of post-partum family planning (PPFP) methods such as post-partum intrauterine device (PPIUD) in general remains low despite its benefits for the women. The reasons or factors affecting the uptake and continuation of such PPFP methods in developing countries such as Nepal remains unclear. This qualitative research aims to explore the factors

2019 BMC Pregnancy and Childbirth

36. Extensive intravesical benign hyperplasia induced by an extravesical migrated intrauterine device: A case report. Full Text available with Trip Pro

Extensive intravesical benign hyperplasia induced by an extravesical migrated intrauterine device: A case report. Intravesical migrated intrauterine devices (IUDs) have been reported to cause bladder perforation, stone formation, or malignant transition. However, such extensive intravesical benign hyperplasia caused by an extravesical migrated IUD is firstly reported.A 38-year-old woman suffered from recurrent urinary urgency and dysuria and without macroscopic hematuria for about 1

2019 Medicine

37. Perinatal outcomes including long-term neuropsychiatric hospitalizations of offspring conceived during intrauterine contraceptive device use. (Abstract)

Perinatal outcomes including long-term neuropsychiatric hospitalizations of offspring conceived during intrauterine contraceptive device use. To investigate short-term adverse perinatal outcomes and long-term neuropsychiatric hospitalizations through 18 years of age in offspring conceived during copper intrauterine device (IUD) use.We conducted a population-based cohort study comparing the pregnancy outcomes after 22 weeks of women who conceived with a copper IUD that was removed, women

2019 Contraception

38. Prevalence and predictors of initiation of intrauterine devices and subdermal implants immediately after surgical abortion. (Abstract)

Prevalence and predictors of initiation of intrauterine devices and subdermal implants immediately after surgical abortion. To estimate uptake of long-acting reversible contraception (LARC) methods immediately after surgical abortion in a system that makes these methods readily available, and to determine demographic, medical, social, and visit-specific predictors of immediate post-abortion intrauterine device (IUD) and implant initiation.We performed a retrospective cohort study of LARC (...) (levonorgestrel intrauterine system [IUS], copper IUD, and subdermal implant) initiation at the time of surgical abortion up to 21w0d gestation at Planned Parenthood League of Massachusetts from 2012 through 2017. We calculated proportions of IUD and implant initiation and used mixed effect logistic regression to estimate predictors of each outcome.Among 26,858 surgical abortion patients, 25.4% received immediate post-abortion LARC: 14.2%, 4.2%, and 7.0% received a levonorgestrel IUS, copper IUD, and implant

2019 Contraception

39. A prospective cohort study comparing expulsion after postplacental insertion: the levonorgestrel versus the copper intrauterine device. (Abstract)

A prospective cohort study comparing expulsion after postplacental insertion: the levonorgestrel versus the copper intrauterine device. To compare the expulsion rate at 6 months after postplacental insertion by intrauterine device (IUD) type.This prospective cohort included participants with a postplacental IUD inserted after vaginal or cesarean delivery, aged 18-45 and ≥24 weeks' gestation. Study enrollment took place after IUD selection and insertion. Participants returned for a postpartum (...) , 95% confidence interval 0.22-4.48).The expulsion rate at 6 months after postplacental insertion did not differ between the levonorgestrel and copper IUD type.Prior studies demonstrate a wide range of expulsion after postplacental insertion, and recent data suggest a higher expulsion rate for the levonorgestrel compared to the copper intrauterine device. However, many studies did not control for patient-level factors or delivery route. We found that when controlling for these confounding variables

2019 Contraception

40. Controversies in family planning: intrauterine device placement in solid organ transplant patients. (Abstract)

Controversies in family planning: intrauterine device placement in solid organ transplant patients. With an ever-increasing number of reproductive-aged women undergoing solid organ transplant and fertility improving after transplant, knowledge of the safety and efficacy of various contraceptive methods is essential to guide patient selection. We present the case of a 22-year-old patient desiring an intrauterine device (IUD) for contraception with a history of liver transplant as a child

2019 Contraception

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>